Mitsubishi UFJ Asset Management’s CG Oncology CGON Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$412K	Buy	+5,800	New	+$379K	﹤0.01%	928

Other funds holding CGON

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mitsubishi UFJ Asset Management's CGON Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management opened a new position in CG Oncology (CGON) in Q2 2026: 5,800 shares worth $412K. The stake represents ﹤0.01% of the portfolio and ranks #928 among its holdings.

71 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

Mitsubishi UFJ Asset Management held 5,800 shares of CG Oncology worth $412K as of Q2 2026.
CG Oncology was a new Mitsubishi UFJ Asset Management position in Q2 2026.
CG Oncology made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #928 holding.
71 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.